Gaush Meditech (HKG:2407) unit Teleon Surgical received an MDR CE certificate for its hydrophilic acrylic intraocular lens (IOL) portfolio, which comprises LENTIS, FEMTIS, and VISIOTIS.
The approval is a key step towards full MDR CE certification of the entire portfolio based on the hydrophilic materials self-developed by the company, as it could lead to cost reductions and long-term supply security of raw materials, according to a Monday filing with the Hong Kong bourse.
Gaush Meditech sees this as a milestone in the subsidiary's transition from the Medical Device Directive (MDD) to the Medical Device Regulation (MDR), the filing stated.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。